glp-1- Questions about GLP-1s? A Providence Swedish weight loss expert has answers Decoding GLP-1 Weight Loss Medications

These changes contribute to a lower risk of cardiovascular disease and other chronic conditions related to obesity

Precision medicine isnt only about the drugits about matching the right biology, the right therapy, and the right care pathway

General: Rybelsus and Ozempic tablets are not substitutable on a mg to mg basis

The Bottom Line Orforglipron (Foundayo) is not simply "Ozempic in pill form." It represents a different molecular strategy for activating the GLP-1 receptor, and that difference may significantly expand access for people who are unwilling or unable to use injectable medications

Cardiovascular outcomes, long-term efficacy and safety In people with T2D and established cardiovascular disease, the international guidelines for T2D recommend the use of GLP-1 RA or sodium glucose co-transporters 2 inhibitors (SGLT-2i) as first-line treatment (independent of HbA1c), based on multiple trials demonstrating their cardio-renal benefits [109]